• Published On: 02/28/2023

  Industry Excoriates MA 2024 Rate Notice

  Read Article
• Published On: 02/25/2023

  Gene Therapy Legislation Codifies Best Price(s)

  Read Article
• Published On: 02/17/2023

  PBM Transparency Act Likely to Pass Senate Committee

  Read Article
• Published On: 02/14/2023

  3 Drug Pilots: Cell & Gene in Medicaid, $2Medicare Generics & Accelerated Approval Pay

  Read Article
• Published On: 02/08/2023

  Biden’s Second State of the Union

  Read Article
• Published On: 02/01/2023

  2024 MA Rates Proposed -2.27%

  Read Article
• Published On: 01/19/2023

  CMS Doubles Down On Value-Based Care

  Read Article
• Published On: 12/20/2022

  Life Science Wins In Omnibus

  Read Article
• Published On: 12/19/2022

  2-Year Omnibus Includes Health Policy

  Read Article
• Published On: 12/13/2022

  CMS 2024 Notice of Benefit & Payment Proposal

  Read Article
• Published On: 12/07/2022

  ePrior Auth CMS Proposal Aids Hospitals & Docs

  Read Article
• Published On: 11/21/2022

  FTC Unfair Methods of Competition

  Read Article
• Published On: 10/14/2022

  Biden Signs EO Drug Pricing

  Read Article
• Published On: 10/10/2022

  FTC Indicates PBM Law Enforcement & Market Rule

  Read Article
• Published On: 09/29/2022

  5 Year FDA User Fee Authorization

  Read Article
• Published On: 09/27/2022

  CMS Requires Broker Call Recording Oct. 1

  Read Article
• Published On: 09/22/2022

  FDA User Fees Likely Pass With Budget Next Week

  Read Article
• Published On: 09/20/2022

  FDA Report Card

  Read Article
• Published On: 09/14/2022

  MA Prior Authorization Bill Advances

  Read Article
• Published On: 09/08/2022

  Multi-Cancer Bill Likely Passes By Year-End

  Read Article

Previous91011Next